Ocular Rosacea

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-09
Clinical Trial Update: Ocular Rosacea Biome Study [Phase 4]
Phase 4 clinical trial update from University of California, San Francisco focusing on ocular rosacea; the study is currently active but not…
CLINICAL_TRIALS trial_result · 2026-03-02
Clinical Trial Update: Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE) [Phase 2]
A Phase 2 clinical trial evaluating Lotilaner ophthalmic gel for ocular rosacea is currently enrolling by invitation.
CLINICAL_TRIALS research · 2024-06-20
Clinical Trial Update: Research Into Diagnostic and Prognostic Molecular and Imaging Biomarkers of Ocular Disorders Associated With Neurovascular Deregulation: Biocor Cohort [NA]
A study called Biocor Cohort is investigating molecular and imaging biomarkers for ocular disorders associated with neurovascular deregulati…
CLINICAL_TRIALS withdrawal · 2023-06-18
Clinical Trial Update: Efficacy and Safety of Dextenza Compared to Topical Fluorometholone in Patients With Ocular Rosacea [Phase 4]
Clinical trial investigating Dextenza versus topical fluorometholone in ocular rosacea was withdrawn during Phase 4.
CLINICAL_TRIALS trial_result · 2020-01-03
Clinical Trial Update: Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea [NA]
A completed clinical trial investigating IPL treatment for ocular rosacea and dry eye; results posted in 2020.
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
CLINICAL_TRIALS withdrawal · 2018-04-26
Clinical Trial Update: Effect of Meibomian Gland Probing on Ocular Surface in Ocular Rosacea [NA]
The clinical trial evaluating meibomian gland probing for ocular surface disease in ocular rosacea has been withdrawn.
CLINICAL_TRIALS trial_result · 2015-11-25
Clinical Trial Update: IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD [NA]
Completed Mayo Clinic trial evaluated intense pulsed light and Meibomian gland expression for treating ocular rosacea and ocular GVHD, with …